KARYOPHARM THERAPEUTICS INC KPTI 3 10.15.25
NOTE 3.000%10/1 · US DOMESTIC · CUSIP 48576UAA4
6
institutional holders
+0 vs Q1 2025
2.0m
shares reported held*
$17.8mreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.89.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 10 |
| Q4 2022 | 11 |
| Q1 2023 | 12 |
| Q2 2023 | 12 |
| Q3 2023 | 12 |
| Q4 2023 | 12 |
| Q1 2024 | 12 |
| Q2 2024 | 6 |
| Q3 2024 | 7 |
| Q4 2024 | 6 |
| Q1 2025 | 6 |
| Q2 2025 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 0 | 0 |
| Q4 2023 | 5 | 1 |
| Q1 2024 | 2 | 3 |
| Q2 2024 | 2 | 8 |
| Q3 2024 | 2 | 1 |
| Q4 2024 | 1 | 3 |
| Q1 2025 | 0 | 0 |
| Q2 2025 | 0 | 0 |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Affinity Asset Advisors, LLC 1.72% of their portfolio | 15.2m $11.6m | Unchanged |
| Opaleye Management Inc. 0.92% of their portfolio | 6.0m $4.6m | Unchanged |
| Exome Asset Management LLC 1.30% of their portfolio | 2.0m $1.5m | Unchanged |
| BLB&B Advisors, LLC 0.00% of their portfolio | 75.0k $56.9k | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 38.0k $29.8k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |